Brazil commits US$ 72 million to Gavi’s 2026–2030 strategic period, reinforcing its role as a key stakeholder in global health and vaccine manufacturing.

Gavi, in collaboration with global health partners, has commenced the design phase of a new maternal vaccine programme targeting RSV burden in lower-income countries.

Hungary makes first-ever pledge to Gavi, the Vaccine Alliance with EUR 1 million commitment, joining a growing group of new donors to Gavi’s 2026–2030 funding cycle.

Gavi CEO Dr Sania Nishtar introduces the Gavi Leap, transforming the Vaccine Alliance for the future through simplicity, transparency and synergy.

If today’s leaders fail to ensure that all countries have the resources they need to identify new disease outbreaks and respond quickly, we will all be at risk, argue Gavi's Sania Nishtar and the European Investment Bank's Nadia Calvino.

Routine immunizations are essential for children to thrive.